Note · 10 November 2026
Peptide Storage: What Was Measured and What Was Repeated
The storage figures repeated for research peptides trace mostly to three supplier handbooks, which cite no data and disagree with one another. Measured studies support narrower findings: degradation rates that varied with sequence, pH, temperature and residual water; freezing losses tied to the molecule, the matrix and the freezing rate rather than the cycle count; and dilute peptides lost to container walls.
What the measured literature supports
Measured studies support four statements about peptide storage, each tied to the molecules tested: degradation rates depended on sequence, pH and buffer, and in some systems on temperature and on residual water in the dried solid; freezing harmed some peptides and spared others, and short repeated freeze-thaw cycles left the peptides tested in solution unchanged; dilute peptides were lost to glass and plastic container walls; and ultraviolet and visible light damaged specific residues and bonds under defined conditions. No study located for this note measured how long a research peptide vial keeps at minus 20 degrees C or after reconstitution, and the figures in circulation for both trace to supplier handbooks or to nothing.
Four storage claims travel in fixed form: that lyophilised peptides keep for years at minus 20 degrees C, that a reconstituted peptide keeps 2 to 4 weeks refrigerated, that freeze-thaw cycles destroy peptides, and that light degrades them. This site's note on lyophilisation recorded that drying moves degradation rather than ending it. This note traces each claim to its source and sorts the results into three classes: measured, guidance and untraced.
Three handbooks, three sets of figures
GenScript's storage guide places lyophilised peptides at minus 20 degrees C away from bright light and states that most are stable for several years under those conditions, while noting that stability depends on sequence. Sigma-Aldrich's guide for peptides and proteins assigns minus 20 degrees C to short-term storage of one to two weeks and minus 80 degrees C to longer storage, and gives peptide solutions, in general, up to a week at 4 degrees C. Bachem's guide, chapter 8 of its online peptide guide, puts the lyophilisate below minus 15 degrees C for longer storage, prefers minus 50 degrees C or lower for the long term, allows 4 degrees C for short-term use, and gives frozen solutions a few weeks. None of the three pages cites a study, a dataset or a reference for any of these figures.
The handbooks disagree on the headline number. Minus 20 degrees C is a multi-year condition in one and a short-term condition of one to two weeks in another, and the third gives no duration for dry powder at all. The 2 to 4 week refrigerated figure appears in none of them: Sigma-Aldrich's refrigerated figure for solutions is one week, Bachem's few weeks applies to frozen solutions, and GenScript gives no duration and advises against keeping peptides in solution. A PubMed search on 10 November 2026 pairing peptides with reconstitution, refrigeration and stability returned 37 records on particular products and molecules, none stating a general figure. The 2 to 4 week figure is recorded here as untraced.
Rates measured in solution ran from days to years
In solution, sequence and conditions set the pace. Geiger and Clarke reported in 1987 that the synthetic hexapeptide Val-Tyr-Pro-Asn-Gly-Ala deamidated with a half-life of 1.4 days at 37 degrees C and pH 7.4, through a succinimide intermediate that hydrolysed with a half-time of 2.3 hours. Replacing the asparagine with aspartic acid slowed succinimide formation 34-fold, and replacing the neighbouring glycine with leucine or proline slowed degradation by a factor of 33 to 50.
Helm and Müller reported in 1990 that gonadorelin and triptorelin, two decapeptides, were most stable near pH 5.0 and degraded faster in phosphate than in acetate. In 0.1 M acetate at pH 5.0 with 3 per cent mannitol, their predicted times to 10 per cent loss were 9.0 and 7.7 years at 20 degrees C. Those are predictions for two sequences in one buffer, not measurements of years elapsed.
Closer to the circulating figure, Bui and colleagues in 2020 held the vasopressin analogue terlipressin at 0.034 mg/mL in 0.9 per cent sodium chloride in three elastomeric infusor devices at 2 to 8 degrees C, assaying in triplicate. After 144 hours each device stayed within 1 per cent of its starting concentration, and a further 24 hours at 22.5 degrees C left every sample above 98 per cent. The measurement ended at 144 hours and says nothing about a third or fourth week, or about any other sequence.
Water in the dried solid
Strickley and Anderson freeze-dried human insulin from 1.0 mg/mL solutions at pH 2 to 5 and held the powders at a range of relative humidities at 35 degrees C. Their 1996 study found that degradation rose with water content even at hydration well below the suspected glass transition, approaching the rate in solution at the 20 to 50 per cent water needed to induce one.
Oliyai and colleagues found a different balance in 1994. They lyophilised the same hexapeptide that Geiger and Clarke had measured and varied starting pH, temperature and residual moisture in a factorial design: the pH of the starting solution had a significant effect, moisture and temperature proved less significant, and how much either mattered depended on that pH.
Hengsawas Surasarang and colleagues lyophilised the peptide CSP7 with mannitol or lactose in sealed glass vials under nitrogen in 2018. Kept dry at 5 degrees C for 10 months, five formulations retained 92.7 to 97.4 per cent potency in triplicate, while the one with the least mannitol aggregated. Cakes held for 8 weeks at 5 or 25 degrees C outside a desiccator took up water, most likely around the rubber stoppers in the authors' judgement, reaching 1.99 and 1.36 per cent, and turned turbid with insoluble aggregates on reconstitution. After 12 hours at 75 per cent relative humidity and 25 degrees C, lactose cut aggregate formation as much as 20-fold where more mannitol did little.
All three handbooks address moisture as guidance without data; its measured effect differed by molecule, excipient and pathway.
Freezing, thawing and the cycle count
GenScript states that peptides undergoing freeze-thaw cycles are susceptible to degradation, and Sigma-Aldrich extends its warning about repeated cycles to lyophilised powder as well as solutions; Bachem's page does not address cycles. A PubMed search on 10 November 2026 for freeze-thaw studies of lyophilised peptides in the solid state returned two records, and neither put a dry peptide through repeated cycles. Applied to powder, the warning is recorded here as untraced.
For solutions, the measurements located implicate the molecule and the manner of freezing more than the count. The CSP7 study froze a 0.5 mg/mL solution for an hour at minus 20 or minus 80 degrees C and thawed it for an hour at room temperature, five times over; about 100 per cent remained, with no aggregation. In 2015 Wewer Albrechtsen and colleagues spiked synthetic GLP-1 and glucagon into plasma pooled from 20 donors, with enzyme inhibitors added and six to ten aliquots per condition; up to three cycles of about an hour at minus 20 degrees C left recoveries unchanged.
Frozen storage was another matter for glucagon in that study. Its recovery fell by almost half within a month at both minus 20 and minus 80 degrees C and drifted lower to six months, a loss seen in plasma but not in an albumin buffer, while GLP-1 was unchanged for 12 months at either temperature. Cao and colleagues showed in 2003 that the manner of freezing mattered for three model enzymes at 0.025 g/L without cryoprotectant: slow freezing near 1 degree C per minute with thawing faster than 10 degrees C per minute recovered more activity, and freezing faster than 20 degrees C per minute with slow thawing did more damage, which they attributed to the larger ice-liquid interface and to recrystallisation during thawing.
Container walls and light
Loss to the container is a measured effect that none of the three handbook pages mentions. Kristensen and colleagues quantified three cationic peptides, mastoparan X, melittin and magainin 2, by HPLC in 2015. At 1 micromolar in 220 microlitres, only 10 to 20 per cent was recovered after an hour in borosilicate glass or polypropylene. Recovery rose with concentration and low-binding tubes lost less, but after a 5 micromolar solution was moved through four glass or polypropylene containers in turn, recovery approached zero. Mastoparan X adsorbed within seconds.
GenScript and Sigma-Aldrich both place peptides away from bright light without defining the term, and Bachem's page does not mention light. Mozziconacci and Schöneich irradiated oxytocin at 253.7 nm and at 290 nm and above in 2012: its disulfide bond converted mainly to a dithiohemiacetal and a thioether, and the dithiohemiacetal broke down further under light or heat, so light followed by heat could yield products different from those of heat alone. Subelzu and Schöneich exposed methionine enkephalin, leucine enkephalin and proctolin to near-ultraviolet and visible light in citrate or acetate buffer containing 1 or 50 micromolar ferric iron in 2021; mannitol, sucrose, trehalose, arginine, lysine and histidine each significantly increased oxidation of peptide methionine to the sulfoxide. The handbook line specifies none of wavelength, buffer, trace metal or excipient.
The test date is where the question starts
A certificate of analysis records a lot as it measured on the day it was tested. It carries no information about the vial afterwards: the temperature in transit, the hours on a bench, the number of openings, the moisture admitted or the light received. Some listings show the lot's test date beside the storage line, as one BPC-157 listing with its lot test date does; that date, not the date of purchase, is the point from which any stability question runs.
Regulated manufacturing keeps the two dates apart. ICH Q7, the good manufacturing practice guide for active pharmaceutical ingredients, lists among a certificate's contents the batch number, the release date and, where one has been assigned, an expiry or retest date, and it bases those dates on stability studies. ICH Q1A(R2) sets the evidence for a freezer claim on a drug substance as real-time data at minus 20 degrees C, plus or minus 5, covering at least 12 months at submission, and permits only limited, justified extrapolation beyond the observed data.
Measured against that standard, the multi-year figure for minus 20 degrees C, with no named formulation, container or dataset behind it, is recorded here as guidance. The 2 to 4 week refrigerated figure is recorded as untraced, the freeze-thaw warning as guidance for solutions and untraced for dry powder, and the light warning as guidance, each beside the measurements described above.
Disclosure. Vialog is published by the team behind Disguised Alpha, which sells the product linked in this note. The note follows the same editorial policy as every other page on this site.
References
- GenScript. Peptide Storage and Handling Guidelines. Supplier handling guide; no author or date shown. Places lyophilised peptides at minus 20 degrees C away from bright light and states that most are stable for several years under those conditions; gives no duration for solutions and advises against storing peptides in solution; states that freeze-thaw cycles leave peptides susceptible to degradation. No study, dataset or reference cited. Guidance, not a study. No PMID. Retrieved 10 November 2026. View on genscript.com
- Sigma-Aldrich. Handling and Storage Guidelines for Peptides and Proteins. Technical article; no author or date shown. Assigns minus 20 degrees C to short-term storage (1 to 2 weeks) and minus 80 degrees C to longer storage; gives peptide solutions, in general, up to a week at 4 degrees C; extends the warning against repeated freeze-thaw cycles to lyophilised peptides and solutions; places peptides away from bright light. No study, dataset or reference cited. Guidance, not a study. No PMID. Retrieved 10 November 2026. View on sigmaaldrich.com
- Bachem. Handling and Storage Guidelines for Peptides. The Online Peptide Guide, chapter 08 of 10; no author or date shown. Lyophilisate below minus 15 degrees C for longer storage, with minus 50 degrees C or lower preferred for long-term storage; refrigerator at 4 degrees C for short-term use; frozen solutions may be kept a few weeks; no duration stated for dry powder; no mention of light or of container material. No study, dataset or reference cited. Guidance, not a study. No PMID. Retrieved 10 November 2026. View on bachem.com
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-94. PMID 3805008 View on pubmed.ncbi.nlm.nih.gov
- Helm VJ, Müller BW. Stability of gonadorelin and triptorelin in aqueous solution. Pharm Res. 1990;7(12):1253-6. DOI 10.1023/a:1015981704133. PMID 2151342 View on pubmed.ncbi.nlm.nih.gov
- Bui TNN, Sandar S, Luna G, Beaman J, Sunderland B, Czarniak P. An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome [title as published by the journal; the study measured drug concentration in infusor devices and involved no patients]. Sci Rep. 2020;10(1):21037. DOI 10.1038/s41598-020-78044-4. PMID 33273555. Device numbers, triplicate assays, Table 4 (2 to 8 degrees C to 144 hours) and Table 5 (24 hours at 22.5 degrees C) read in the full text, PMC7712657. View on pubmed.ncbi.nlm.nih.gov
- Strickley RG, Anderson BD. Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Pharm Res. 1996;13(8):1142-53. DOI 10.1023/a:1016043715791. PMID 8865303 View on pubmed.ncbi.nlm.nih.gov
- Oliyai C, Patel JP, Carr L, Borchardt RT. Solid state chemical instability of an asparaginyl residue in a model hexapeptide. J Pharm Sci Technol. 1994;48(3):167-73. Page range from the publisher's record; PubMed indexes it as 167-23. PMID 8069519 View on pubmed.ncbi.nlm.nih.gov
- Hengsawas Surasarang S, Florova G, Komissarov AA, Shetty S, Idell S, Williams RO. Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis [title as published by the journal; the study measured formulation stability in vials and during nebulisation and involved no patients]. Drug Dev Ind Pharm. 2018;44(2):184-198. DOI 10.1080/03639045.2017.1371736. PMID 28835128. Freeze-thaw protocol and result, 10-month potencies (n = 3), 8-week moisture values and the 75 per cent relative humidity exposure read in the full text, PMC6112109. View on pubmed.ncbi.nlm.nih.gov
- Wewer Albrechtsen NJ, Bak MJ, Hartmann B, Christensen LW, Kuhre RE, Deacon CF, Holst JJ. Stability of glucagon-like peptide 1 and glucagon in human plasma. Endocr Connect. 2015;4(1):50-7. DOI 10.1530/EC-14-0126. PMID 25596009. Cycle protocol (about 1 hour at minus 20 degrees C, thawed on ice), aliquot numbers, long-term time course and the plasma-versus-albumin-buffer comparison read in the full text, PMC4317691. View on pubmed.ncbi.nlm.nih.gov
- Cao E, Chen Y, Cui Z, Foster PR. Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol Bioeng. 2003;82(6):684-90. DOI 10.1002/bit.10612. PMID 12673768 View on pubmed.ncbi.nlm.nih.gov
- Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLoS One. 2015;10(5):e0122419. DOI 10.1371/journal.pone.0122419. PMID 25932639. Concentrations, volumes, container types and recoveries read in the full text, PMC4416745. View on pubmed.ncbi.nlm.nih.gov
- Mozziconacci O, Schöneich C. Photodegradation of oxytocin and thermal stability of photoproducts. J Pharm Sci. 2012;101(9):3331-46. DOI 10.1002/jps.23204. PMID 22623074 View on pubmed.ncbi.nlm.nih.gov
- Subelzu N, Schöneich C. Pharmaceutical excipients enhance iron-dependent photo-degradation in pharmaceutical buffers by near UV and visible light: tyrosine modification by reactions of the antioxidant methionine in citrate buffer. Pharm Res. 2021;38(5):915-930. DOI 10.1007/s11095-021-03042-8. PMID 33881737 View on pubmed.ncbi.nlm.nih.gov
- International Council for Harmonisation. ICH Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Step 4, 10 November 2000. Section 11.41 (certificate of analysis to give the batch number, the date of release and, where assigned, the expiry or retest date) and section 11.61 (expiry or retest dates based on an evaluation of stability data). No PMID; regulatory guideline. Retrieved 10 November 2026. View on database.ich.org
- International Council for Harmonisation. ICH Q1A(R2), Stability Testing of New Drug Substances and Products. Step 4, 6 February 2003. Sections 2.1.7.3 and 2.2.7.5 (freezer storage: long term at minus 20 degrees C plus or minus 5, minimum 12 months of data at submission, re-test period or shelf life based on real-time data), 2.1.9 (limited extrapolation beyond the observed range, if justified) and the glossary definitions of re-test period and shelf life. The ICH site listed Q1A(R2) as current on retrieval; a consolidated revision, ICH Q1, reached Step 2b on 11 April 2025 and was at Step 3. No PMID; regulatory guideline. Retrieved 10 November 2026. View on database.ich.org